![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as – Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner](https://www.researchgate.net/publication/342155003/figure/fig2/AS:962718530027525@1606541392511/Glutathione-GSH-attenuated-MPP-and-GSH-depletion-BSO-induced-increase-in-cell-death.png)
bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as – Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner
PDF] Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Semantic Scholar Development of a mouse model expressing a bifunctional glutathione synthesizing enzyme to study glutathione limitation in vivo Journal of Biological Chemistry A novel small molecule that induces cytotoxicity in lung cancer cells inhibits disulfide reductases GSR and TXNRD1 bioRxiv Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L buthionine sulfoximine Cell Death & Differentiation Inhibition of glutathione metabolism attenuates esophageal cancer progression Experimental & Molecular Medicine
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/5fac76d6ebe16906329204d929b1af00b50c2fd3/3-Figure1-1.png)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner](https://www.jbc.org/cms/10.1016/j.jbc.2024.105645/asset/b870036e-2f1a-4ef5-822e-1787ba13fc72/main.assets/gr1_lrg.jpg)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner](https://www.biorxiv.org/content/biorxiv/early/2021/06/28/2021.06.28.450088/F5.large.jpg)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.cdd.4401389/MediaObjects/41418_2004_Article_BF4401389_Fig1_HTML.jpg)
![bso glutathione inhibitor The synthesis buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Buthionine (S Multiomics reveals glutathione metabolism as Buthionine sulfoximine PDF] Targeting Glutathione Metabolism: Partner](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Femm.2017.15/MediaObjects/12276_2017_Article_BFemm201715_Fig3_HTML.jpg)